Literature DB >> 14558399

Phosphatidylcholine in the treatment of localized fat.

Doris Hexsel1, Marcio Serra, Rosemari Mazzuco, Taciana Dal'Forno, Debora Zechmeister.   

Abstract

Phosphatidylcholine was initially used in emergencies and in the treatment of atheroma plaques in cardiac diseases. Recently, it has also been used in the treatment of localized fat deposits. We report on the authors' clinical experience of the use of 250 mg/ml phosphatidylcholine injections in the treatment of subcutaneous fat deposits, showing the clinical response and side-effects. Volunteers received phosphatidylcholine injections in several areas of localized fat deposits, with a minimum interval of one week and mean interval of 15 days between applications. Laboratory tests were performed during the period of the drug use. Clinical results reflect that phosphatidylcholine was efficacious in reducing the fatty pads in the treated areas, with few side effects. From the authors' point of view, the off-label use of phosphatidylcholine in the treatment of fatty pads and small areas of localized fat is safe, low cost, and effective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14558399

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  8 in total

1.  [Injection lipolysis].

Authors:  K Hoffmann
Journal:  Hautarzt       Date:  2010-10       Impact factor: 0.751

2.  The effect of phosphatidylcholine and deoxycholate compound injections to the localized adipose tissue: an experimental study with a murine model.

Authors:  Yongjoon Noh; Chan-Yeong Heo
Journal:  Arch Plast Surg       Date:  2012-09-12

Review 3.  Injection therapy for the management of superficial subcutaneous lipomas.

Authors:  Kyle T Amber; Steven Ovadia; Ivan Camacho
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

4.  Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: a randomized, controlled trial.

Authors:  Dominic N Reeds; B Selma Mohammed; Samuel Klein; Craig Brian Boswell; V Leroy Young
Journal:  Aesthet Surg J       Date:  2013-02-25       Impact factor: 4.283

5.  Predictability of the individual clinical outcome of extracorporeal shock wave therapy for cellulite.

Authors:  Kai-Uwe Schlaudraff; Maren C Kiessling; Nikolaus Bm Császár; Christoph Schmitz
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-05-23

6.  Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat.

Authors:  James McDiarmid; Jesus Benito Ruiz; Daniel Lee; Susanne Lippert; Claudia Hartisch; Blanka Havlickova
Journal:  Aesthetic Plast Surg       Date:  2014-07-02       Impact factor: 2.326

7.  Selective effect of phosphatidylcholine on the lysis of adipocytes.

Authors:  Ji-Young Kim; Min-Seo Kwon; Junghyun Son; Sang-Wook Kang; Youngsup Song
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

8.  Injection Lipolysis: A Systematic Review of Literature and Our Experience with a Combination of Phosphatidylcholine and Deoxycholate over a Period of 14 Years in 1269 Patients of Indian and South East Asian Origin.

Authors:  Mohan K Thomas; James A D'Silva; Ateesh J Borole
Journal:  J Cutan Aesthet Surg       Date:  2018 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.